Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
Ole FröbertMatthias GötbergDavid ErlingeZubair AkhtarEvald H ChristiansenChandini R MacIntyreKeith G OldroydZuzana MotovskaAndrejs ErglisRasmus MoerOta HlinomazLars JakobsenThomas EngstrømLisette O JensenChristian O FallesenSvend E JensenOskar AngeråsFredrik CalaisAmra KåregrenJörg LauermannArash MokhtariJohan NilssonJonas PerssonPer StalbyAbu K M M IslamAfzalur RahmanFazila MalikSohel Reza ChoudhuryStuart J PocockStuart J PocockJohn PernowPublished in: Circulation (2021)
Influenza vaccination early after an MI or in high-risk coronary heart disease resulted in a lower risk of a composite of all-cause death, MI, or stent thrombosis, and a lower risk of all-cause death and cardiovascular death, as well, at 12 months compared with placebo. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02831608.